| Jeff A D'ambrosio, PA-C | |
|
215 Riverstone Dr, Canton, GA 30114-5256 | |
| (770) 345-6600 | |
| (770) 345-6611 |
| Full Name | Jeff A D'ambrosio |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 19 Years |
| Location | 215 Riverstone Dr, Canton, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457553927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 004621 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Ent Associates Pc | 2264498807 | 16 |
News Archive
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company's novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria. DermaVir, the first dendritic cell-targeting topical HIV vaccine candidate, employs nanotechnology to induce multi-faceted and long-lived immune responses capable of eliminating HIV infected cells.
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. Vaccinated mice produced broadly neutralizing antibodies against multiple strains of the MERS coronavirus (MERS-CoV), while vaccinated macaques were protected from severe lung damage when later exposed to MERS-CoV.
Yale University researchers and colleagues in Hong Kong and China have developed an approach for rapidly tracking population flows that could help policymakers worldwide more effectively assess risk of disease spread and allocate limited resources as they combat the COVID-19 pandemic.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeff A D'ambrosio, PA-C 215 Riverstone Dr, Canton, GA 30114-5256 Ph: (770) 345-6600 | Jeff A D'ambrosio, PA-C 215 Riverstone Dr, Canton, GA 30114-5256 Ph: (770) 345-6600 |
News Archive
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company's novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria. DermaVir, the first dendritic cell-targeting topical HIV vaccine candidate, employs nanotechnology to induce multi-faceted and long-lived immune responses capable of eliminating HIV infected cells.
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. Vaccinated mice produced broadly neutralizing antibodies against multiple strains of the MERS coronavirus (MERS-CoV), while vaccinated macaques were protected from severe lung damage when later exposed to MERS-CoV.
Yale University researchers and colleagues in Hong Kong and China have developed an approach for rapidly tracking population flows that could help policymakers worldwide more effectively assess risk of disease spread and allocate limited resources as they combat the COVID-19 pandemic.
› Verified 3 days ago
Uma T Daya, P.A. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 220 Oakside Ln, Canton, GA 30114 Phone: 678-807-1050 Fax: 770-720-7384 | |
Alyssa Giardina, Physician Assistant Medicare: Medicare Enrolled Practice Location: 216 Moore Valley Way, Canton, GA 30115 Phone: 678-710-1312 | |
Mr. Colin Flanagan, PS-S Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 150 Cedar Woods Trl, Canton, GA 30114 Phone: 631-807-5906 | |
Mrs. Kirby Brown Reinecke, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 120 Oakside Ct, Suite H, Canton, GA 30114 Phone: 678-880-8770 Fax: 770-213-4418 | |
Richard F Hamaker, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 220 Oakside Ln, Canton, GA 30114 Phone: 678-807-1050 Fax: 678-807-1055 | |
Mr. Eddy Toussaint, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 460 Northside Cherokee Blvd Ste 100, Canton, GA 30115 Phone: 770-292-3490 Fax: 770-721-5615 | |
Rayllensons Itacy, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2020 Cumming Highway, Suite 102, Canton, GA 30115 Phone: 678-593-1295 Fax: 678-593-1294 |